{"schema_version":"secwatch.filing_event.v1","accession":"0001513162-23-000034","form_type":"8-K","ticker":"BMRA","cik":"0000073290","company_name":"BIOMERICA INC","filed_at":"2023-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.934948+00:00","generated_at":"2026-06-18T10:49:13.862731+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Biomerica closes $8M public offering of 3.33M shares at $2.40/share","bullets":["Raised $8M gross, ~$7.4M net from 3,333,333 shares at $2.40/share via Craig-Hallum.","Net proceeds for clinical studies, sales expansion, R&D, acquisitions, and working capital.","Directors and officers agreed to 90-day lock-up on stock sales post-closing.","Offering closed March 7, 2023; underwriter discount 6%."],"urls":{"canonical":"https://secwatch.observer/filing/0001513162-23-000034","json":"https://secwatch.observer/filing/0001513162-23-000034.json","markdown":"https://secwatch.observer/filing/0001513162-23-000034.md","text":"https://secwatch.observer/filing/0001513162-23-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000034/0001513162-23-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000034/bmra-20230303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T10:49:13.862731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06b6e04d90d4cfc8e4fc720186e482ef2587747c","claim":"BIOMERICA INC entered into Underwriting Agreement with Craig-Hallum Capital Group LLC valued at 3,333,333 shares of Common Stock at $2.40 per share (effective 2023-03-03).","evidence_excerpt":"On March 3, 2023, Biomerica, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Craig-Hallum Capital Group LLC (the “Underwriter”), relating to the issuance and sale in an underwritten public offering (the “Offering”) of an aggregate of 3,333,333 shares of the Company’s common stock, par value $0.08 per share (“Common Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000151316223000034/0001513162-23-000034-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Craig-Hallum Capital Group LLC"},{"label":"Value","value":"3,333,333 shares of Common Stock at $2.40 per share"},{"label":"Effective","value":"2023-03-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}